Predicted to enable glycosylceramide flippase activity and phosphatidylcholine flippase activity. Predicted to be involved in lysosomal membrane organization and phospholipid translocation. Predicted to be located in endoplasmic reticulum; late endosome membrane; and lysosomal membrane. Predicted to be part of phospholipid-translocating ATPase complex. Predicted to be active in plasma membrane. Orthologous to human ATP10B (ATPase phospholipid transporting 10B (putative)); INTERACTS WITH bisphenol A; chlormequat chloride; gentamycin.
ATPase phospholipid transporting 10B (putative); ATPase, class V, type 10B; LOC303056; phospholipid-transporting ATPase VB; probable phospholipid-transporting ATPase VB; RGD1565126; similar to novel protein
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...
[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ATP10B mRNA; [S-(1,2-dichlorovinyl)cysteine more ...
[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ATP10B mRNA; [S-(1,2-dichlorovinyl)cysteine more ...
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...